Spectranetics Corporation has recalled 2,939 units of the Intact Vascular Tack Endovascular System, which is used to treat arterial dissections (tears in the artery wall). The recall was issued because the device may experience issues with deployment or become unstable once placed in the blood vessel. These problems can lead to the implant moving, the need for emergency stenting or surgical reintervention, and potential loss of blood flow (ischemia).
If the device fails to deploy correctly or migrates from its intended position, it may fail to treat the damaged artery and could potentially block blood flow. Although no injuries have been specifically detailed in this report, the risks include serious medical complications requiring additional invasive procedures.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.